Blood filtration treatment study for children
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a special blood filtration machine (multiFiltratePRO) in children with kidney failure who need continuous dialysis. It aims to see how well the treatment works and if it's safe for younger patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be under 18 years old
- Weigh between 17.6 pounds (8 kg) and 88 pounds (40 kg)
- Need a specific type of dialysis called CVVHD for kidney problems
- Expected to live more than 3 days
- Parent or guardian must agree to the study, and older children must also agree if they can understand
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood-thinning medications used during continuous dialysis for acute kidney injury: one uses citrate (a chemical that prevents clotting) and the other uses heparin (a standard blood thinner). By looking at how well these treatments work, the study aims to find the safest and most effective way to keep the dialysis filter working.
This study is for adults who are starting continuous kidney replacement therapy (CRRT) for kidney failure. It looks at how well the filter removes waste, and excludes people on ECMO.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This study tests how well a specific automated peritoneal dialysis (APD) treatment works and how tolerable it is for children with kidney failure. It is designed for small children weighing 20 kg or less who need or already use APD.
This study looks at improving how well dialysis removes waste from the blood and uses water in children. It may help make treatments more effective and efficient.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
Hear when a new Renal Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.